Egypt Sickle cell disease Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Sickle cell disease Drugs is growing rapidly as a result of increasing prevalence of sickle cell disease , increasing investment for healthcare infrastructure, increase in the number of research and development activities, Support provided by governments of different countries, patient advocacy programmes and incentives provided by regulatory authorities. Global Blood Therapeutics, Novartis, Emmaus Life Sciences, Bluebird Bio, Teva Pharmaceutical Industries Ltd, Pfizer Inc., Mylan N.V., Merck & Co., Inc., Johnson & Johnson Private Limited, Bristol-Myers Squibb Company, AbbVie Inc are the key global market players operating in sickle cell disease Drugs market.
Egypt Soft Tissue Sarcoma market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Soft Tissue Sarcoma is growing rapidly as a result of increasing prevalence and incidence of soft tissue sarcoma, rising awareness about the disease, rising research and development activities on drugs and other therapies, increase in partnerships between pharmaceutical companies for drug development and advancements in diagnostics. Pfizer Inc, Eli Lilly and Company, Johnson & Johnson, Bayer AG, Eisai Co., Ltd., Epizyme, Inc., Adaptimmune Therapeutics, Mylan N.V., Sanofi are the key market players operating in global Soft Tissue Sarcoma market.
Egypt Wilson?s Disease Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Wilson?s Disease Drugs is growing rapidly as a result of rising prevalence of the disease, advancements in diagnostic techniques , increase in awareness about the disease due to patient advocacy programmes , support and incentives from regulatory authorities like incentives and orphan drug designations and increasing investment in research and development activities. Amneal Pharmaceuticals, Meda Pharmaceuticals, Teva Pharmaceuticals Industries Ltd. , Taj Pharmaceutical Limited, Ipsen Pharma, TSUMURA & CO., Mylan pharmaceuticals are the key global market players in wilson?s disease drugs market.
Egypt X-Linked Myotubular Myopathy (XLMTM) Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for X-Linked Myotubular Myopathy (XLMTM) Drugs is growing rapidly as a result of unmet medical need for therapies of X-Linked Myotubular Myopathy (XLMTM) disease, advancements in gene therapy, Growing Awareness and Patient Advocacy about the disease, Increased Research and Collaboration between research organizations and pharmaceutical companies, supportive regulatory environments, Technological Advancements in gene sequencing and biomarker identification. Novartis Gene Therapies, Avrobio, Axovant Gene Therapies, Sarepta Therapeutics, Amicus Therapeutics, Sanofi Genzyme, Pfizer, Audentes Therapeutics are the key market players operating in global X-Linked Myotubular Myopathy (XLMTM) Drugs market.
Egypt Acromegaly Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. The prevalence and incidence of acromegaly and pituitary tumours are rising, as is global awareness of the disease. Technological advances in the development of new acromegaly medications are also key contributors to the market's growth. The high prevalence of hormonal problems, evolving lifestyles, and rising genetic disease incidence are all anticipated to fuel market expansion.Some of the key players in the global acromegaly therapeutics Market include Roche, Sanofi, GSK, Pfizer INC., Ipsen, Chiasma Inc, Validus pharmaceuticals LLC., Novartis AG, Amryt, Recordati, Sun Pharma, Crinetics Pharmaceuticals, Camurus, Ionis Pharmaceuticals , and Others.
Egypt Adrenoleukodystrophy (ALD) Drugs Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Drivers of acromegaly market are increasing cases of the disorder which in turn increased awareness and government focus motivated financial support to R&D. Poxel SA, Bluebird Bio Inc.,Viking Technologies, Minoryx Therapeutics sl., Apteeus SAS, Ashvattha Therapeutics LLC, NeuroVia Company, Autobahn Therapeutics Inc., Aldagen Inc., Celularity Inc., Imstem Biotechnology Inc., MedDay SA, and Orpheris Inc. are major competitors in the Egypt Adrenoleukodystrophy (ALD) drugs market.
Egypt during the forecast period of 2023-30, the Alport Syndrome therapeutics market is anticipated to increase from $xx Mn in 2023 to $xx Mn by 2030, recording a CAGR of xx percent. Almost always affecting the kidney, Alport syndrome is a multisystem condition that also usually affects the inner ear and the eye. A variety of symptoms that normally start in childhood or adolescence and may get worse over time can be present. Invitae Corporation, Hoffmann-La Roche Ltd., Centogene N.V., and Eurofins Discovery are a few of the leading companies in the worldwide Alport syndrome market.
Egypt During the forecast period of 2023?2030, the Anal Fistula Therapeutics Market is anticipated to increase from $xx Mn in 2023 to $xx Mn by 2030, recording a CAGR of xx percent. A rare intestinal ailment that typically appears following an acute perianal abscess and is defined by improper connection between the lower rectum and the perianal skin. The market is expanding more quickly thanks to technological advancements in anal fistula therapy. The development of novel surgical treatment options and the explosive growth of the medical tourism business have contributed to the sector's segment expansion. The leading companies profiled in the market research study on anal fistula treatment include Becton, Medtronic, Dickinson and Company, Gem Srl, Biolitec AG, BD, Johnson & Johnson Services, Inc., Mylan N.V., Takeda Pharmaceutical Company Limited, W. L. Gore & Associates, Cook, KARL STORZ SE & Co. KG, Novartis AG, Boehringer Ingelheim International GmbH, Pfizer.
Egypt During the forecast period of 2023?2030, The Angelman Syndrome Therapeutics Market is anticipated to increase from $xx Mn in 2023 to $xx Mn by 2030, recording a CAGR of xx percent. An uncommon inherited neuro-developmental condition called Angelman Syndrome is marked by a severe developmental delay, sleep issues, jerky movements, and a lot of laughter. As the illness is more common, there are more government measures to manage it. This has also helped with research and development for condition treatment. These factors collectively represent the Angelman Syndrome Therapeutics Market's driving forces. Boston Children's Hospital, the Angelman Syndrome Foundation, Rady Children's Hospital in San Diego, General Hospital Corporation, Cincinnati Children's Hospital Medical Center, and others are major competitors in the market for treating Angelman syndrome.
Egypt Ankylosing Spondylitis Drugs market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023-30. Ankylosing spondylitis is a kind of arthritis that affects connective tissues. The sacroiliac joints, which connect the spine to the pelvis, become inflamed, but in extreme situations, the spine's bones might fuse together and become very inflexible. A rough estimate of 1.1 Mn Americans, or one out of every 200 adults, are impacted. Abbvie, Amgen, Eli Lilly, Janssen, Merck, Pfizer, Novartis, UCB, and many other leading companies are active in the ankylosing spondylitis global market. To increase their market share, these businesses engage in strategic alliances and acquisitions in addition to concentrating on research and development to bring novel therapies to market.
This report presents a strategic analysis of the Egypt Vitamin and Minerals Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Vitamin and Minerals Market, offering unmatched value, accuracy and expert insights.
This report presents a strategic analysis of the Egypt Obesity Drugs Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Egypt Obesity Drugs Market, offering unmatched value, accuracy and expert insights.
Egypt ECG Equipment Market is expected to witness growth from $25 Mn in 2022 to $49 Mn in 2030 with a CAGR of 8.80% for the forecasted year 2022-30. The Egyptian government has made significant investments in the healthcare industry, including the construction of brand-new hospitals and centres as well as the remodelling of already-existing ones. As a result, the demand for ECG equipment has grown. The market is segmented by product type and by the end user. Some key players in this market include Wassenburg Medical, EMG-EP Technologies, Johnson & Johnson, Philipps Healthcare, Medtronic and Dexcom.
Egypt Stem Cell/Cord Blood Banking Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Stem Cell/ Cord Blood Banking is expanding as a result of increase in healthcare and growing awareness among people. This demand is fueling the development of market for Stem Cell/Cord Blood Banking. Some of the key players in the global Stem Cell/Cord Blood Banking Market include CBR Systems, Inc., Cordlife, Cryo-Cell International, Inc., ViaCord, Cryo-Save, LifeCell International Pvt. Ltd., StemCyte India Therapeutics Pvt. Ltd., Global Cord Blood Corporation, Smart Cells International Limited, and Vita 34 International.
Egypt Stroke Management and Care Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Stroke Management and Care is growing as a result of rising prevalence of cardiovascular diseases, growing geriatric population, and advancements in technology. This demand is fueling the development of better care and management for stroke. Some of the key players in the global Stroke Management and Care Market include Abbott Laboratories, B Braun Melsungen AG, Boston Scientific Corporation, Bristol Myers Squibb Co., Merck & Co., GE Healthcare, Siemens AG, Cardinal Health Inc., GlaxoSmithKline Plc, and Medtronic Plc.
Egypt Synthetic Biology Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Synthetic Biology is expanding as a result of rising demand for advancement in gene editing technology and genetic engineering in both developed and developing nations. This demand is fueling the development of better devices and methods for synthetic biology. Some of the key players in the global synthetic biology Market include Bota Biosciences Inc.; Codexis, Inc.; Creative Biogene; CREATIVE ENZYMES; Enbiotix, Inc.; Illumina, Inc.; Merck Kgaa (Sigma-Aldrich Co. LLC); New England Biolabs; Euro fins Scientific; Novozymes; Pareto Bio, Inc.; Scarab Genomics, LLC; Synthego; Synthetic Genomics Inc.; and Thermo Fisher Scientific, Inc.
Egypt Thrombocytopenia Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Thrombocytopenia is expanding as a result of increasing prevalence of thrombocytopenia and development of new treatment options. This demand is fueling the development of better devices and methods for the early and accurate diagnosis and treatment of Thrombocytopenia. Some of the key players in the global Thrombocytopenia Market include Sanofi, Principia Biopharma, Baxalta, Takeda, Argenx, Millennium Pharmaceuticals, Biotest, GC Pharma, Genosco (Subsidiary of Oscotec), Rigel Pharmaceuticals, Kissei Pharmaceutical, Shionogi & Co., Ltd, Amgen, Novartis, and Zenyaku Kogyo.
Egypt Ultrasonic Technology Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Ultrasonic Technology is expanding as a result of rising chronic diseases and innovations in healthcare. This demand is fueling the growth of ultrasonic technology for the early detection and accurate diagnosis of various disease. Some of the key players in the global Ultrasonic Technology Market include Advanced Sonics, LLC, Crest Ultrasonics Corp., DPR Ultrasonic Technologies, Emerson Electric Co. (Branson), International Ultrasonic Technologies, Mosca GmbH, MS Industries AG, Sonotronic Nagel GmbH, Telsonic AG, and Ultrasonic Technologies, Inc.
Egypt Urgent Care Center Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Urgent Care Center is expanding as a result of favorable government policies and increasing prevalence of chronic diseases and accidents. This demand is fueling the development of better infrastructures and facilities for urgent care center. Some of the key players in the global Urgent Care center market include Concentra, Inc.; American Family Care; CityMD Urgent Care; MedExpress Urgent Care; NextCare Urgent Care; Tenet Health Urgent Care; FastMed Urgent Care; Ascension Health Urgent Care; WellNow Urgent Care; Sutter Health; Aurora Urgent Care; and Intuitive Health.
Egypt DNA Sequencing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for DNA Sequencing is expanding as a result of advances in DNA Sequencing technology and increased applications in clinical diagnosis drug discovery. This is raising the demand for the market and is leading to increased investment in research & development for DNA Sequencing. Some of the key players in the global DNA Sequencing Market include Aglient Technologies, Illumina, Inc., Hoffmann-La Roche Ltd., QIAGEN, Perkin Elmer, Thermo Fisher Scientific, Macrogen, Inc., Bio-Rad Laboratories, Inc., Oxford Nanopore Technologies Ltd., Myriad Genetic, and Pacific Biosciences.
Egypt Alzheimer's Disease Diagnostics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2033. The market for Alzheimer's disease diagnostics is expanding as a result of rising healthcare spending in both developed and developing nations. This demand is fueling the development of better diagnostic tools and methods for the early detection and accurate diagnosis of Alzheimer's disease. Some of the key players in the global Alzheimer's Disease Diagnostics Market include Biogen, Eli Lilly and Company, Roche, Merck & Co., GE Healthcare, Siemens Healthineers, Philips Healthcare, Fujirebio, Cogstate, and Advanced Brain Monitoring.
Egypt Ambulance Service Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Ambulance Service is expanding as a result of rising incidence of traumatic accidents and medical tourism in both developed and developing nations. This demand is fueling the development of better infrastructure and services for timely diagnosis and treatment while transportation of patient from one place to healthcare facilities. Some of the key players in the global Ambulance Service Market include Babcock International Group PLC, Acadian Ambulance Service, BVG India Limited, America Ambulance Service, Inc., Falck A/S, Air Methods Corporation, Ziqitza Health Care Limited, Harmonie Ambulance, Envision Healthcare, and Medivic Aviation.
Egypt Ambulatory Surgery Center Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Ambulatory Surgery Center is expanding as a result of Increasing demand for minimal invasive surgeries and rising healthcare expenditure. This demand is fueling the development of better surgical devices and methods for effective and accurate outcomes of ambulatory surgeries. Some of the key players in the global ambulatory surgery center market include Community Health Systems, Inc.; Envision Healthcare Corporation; Terveystalo; Tenet Healthcare Corporation; MEDNAX Services, Inc.; TeamHealth; Quorum Health Corporation; UnitedHealth Group; Surgery Partners; and Healthway Medical Group.
Egypt Antimicrobial Susceptibility Testing Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Antimicrobial Susceptibility Testing is expanding as a result of increasing infectious diseases and rising research and development funding globally. This demand is fueling the development of better tools and methods for antimicrobial susceptibility testing market. Some of the key players in the global Antimicrobial Susceptibility Testing Market include Bio-Rad Laboratories Inc.; Merck & Co., Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; BD; bioM?rieux SA; Creative Diagnostics; Hi-Media Laboratories Pvt. Ltd.; ELITechGroup; and F. Hoffmann-La Roche Ltd.
Egypt Appetite Disorder Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 - 2030. The market for Appetite Disorder is expanding as a result of rising psychiatric illness and increasing prevalence of eating disorders. This demand is fueling the development of better medication and treatment procedures for the early intervention of appetite disorders.Some of the key players in the global Appetite Disorder Market include Bausch & Lomb Incorporated, Somerset Therapeutics, LLC, Equip, Teva Pharmaceuticals Industries Ltd, Mylan N.V., Pfizer Inc., Amneal Pharmaceutical LLC, Sun Pharmaceutical Industries Ltd, Moriah Behavioral Health, and Eli Lilly and Company.